Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma
苯达莫司汀联合利妥昔单抗和替西罗莫司(BeRT)治疗复发性套细胞淋巴瘤和滤泡性淋巴瘤的I/II期临床试验最终结果
期刊:Hemasphere
影响因子:14.6
doi:10.1097/HS9.0000000000000398
Hess, Georg; Wagner, Karola; Keller, Ulrich; La Rosee, Paul; Atta, Johannes; Hübel, Kai; Lerchenmueller, Christian; Schoendube, Daniel; Witzens-Harig, Mathias; Ruckes, Christian; Medler, Christoph; van Oordt, Christina; Klapper, Wolfram; Theobald, Matthias; Dreyling, Martin